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Abstract.  Caveolae or noncoated plasmalemmal vesi- 
cles found in a variety of cells have been implicated in 
a number of important cellular functions including en- 
docytosis, transcytosis, and potocytosis. Their func- 
tion in transport across endothelium has been espe- 
cially controversial, at least in part because there has 
not been any way to selectively inhibit this putative 
pathway. We now show that the ability of sterol bind- 
ing agents  such as filipin to disassemble endothelial 
noncoated but not coated plasmalemmal vesicles selec- 
tively inhibits caveolae-mediated intracellular and 
transcellular transport of select macromolecules in en- 
dothelium. Filipin significantly reduces the transcellu- 
lar transport of insulin and albumin across cultured 
endothelial cell monolayers. Rat lung microvascular 
permeability to albumin in situ is significantly de- 
creased after filipin perfusion. Conversely, paracellular 
transport of the small solute inulin is not inhibited in 
vitro or in situ. In addition, we show that caveolae 
mediate the scavenger  endocytosis of conformationally 
modified albumins for delivery to endosomes and 
lysosomes for degradation. This intracellular transport 
is inhibited by filipin both in vitro and in situ.  Other 
sterol binding agents including nystatin and digitonin 
also inhibit this degradative process.  Conversely, the 
endocytosis and degradation of activated tx2-macro- 
globulin, a known ligand of the clathrin-dependent 
pathway, is not affected. Interestingly, filipin appears 
to inhibit insulin uptake by endothelium for transcyto- 
sis,  a caveolae-mediated process, but not endocytosis 
for degradation, apparently mediated by the clathrin- 
coated pathway. Such selective inhibition of caveolae 
not only provides critical evidence for the role of cav- 
eolae in the intracellular and transcellular transport of 
select macromolecules in endothelium but also may be 
useful for distinguishing transport mediated by coated 
versus noncoated vesicles. 
C 
LATHRIN-COated vesicles are the best characterized 
of the vesicular carriers  and with the clustering of 
receptors at the cell surface provide a specific deliv- 
ery system for a multitude of ligands from the plasmalemma 
to  endosomes  for  cellular  processing  (Goldstein  et  al., 
1985). For many years, the smaller noncoated plasmalem- 
mal vesicles (also known as caveolae) received a second bill- 
ing to the larger and more structurally impressive coated va- 
riety. Although the existence of  caveolae has been known for 
40 years (Yamada, 1955; Palade, G. E. 1953. J. Appl.  Phys- 
ics. 24:1424; and Palade, G. E., Anat. Rec. 1958. 130:467), 
defining  their  precise  function(s)  has  been  somewhat 
difficult. For decades,  noncoated vesicles were thought at 
best to function only in fluid-phase endocytosis and because 
of this conception, they were frequently called pinocytic or 
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"drinking" vesicles (for review see Silverstein et al., 1977). 
One of the interesting functions originally ascribed to these 
structures upon their discovery in endothelium was a poten- 
tial role in the transport of "quanta" of molecular cargo from 
the blood across the endothelium to the tissue interstitium; 
again, fluid phase uptake was envisioned (Palade and Bruns, 
1968). In the interim, more studies have focused on the dis- 
covered role of  clathrin-coated vesicles in receptor-mediated 
endocytosis. 
Recent studies have brought renewed interest in caveolae 
because they may be responsible for various important cellu- 
lar processes ranging from signal transduction to a variety 
of receptor-mediated transport processes including transcy- 
tosis, endocytosis and potocytosis. Distinct endocytosis in- 
dependent of  the clathrin-coated pathway has been described 
in a variety of cell types for various probes including fluid- 
phase markers such as sucrose, ferritin, and horseradish per- 
oxidase (Oliver, 1982; Van Deurs and Nicausen,  1982) and 
membrane-bound  probes  such as cationized  ferritin,  ricin 
(Van Deurs et al., 1990), Con A (Hansen et al., 1991), toxins 
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poprotein  (LDL)  ~ (Mommaas-Kienhuis  et  al.,  1985),  vi- 
ruses  (Kartenbeck et  al.,  1989),  and  specific  antibodies 
recognizing ~-adrenergic receptors (Raposo et al.,  1989), 
glycosylphosphatidylinositol-anchored cell membrane pro- 
teins (Keller et al.,  1992; Bamezai et al.,  1992), and human 
lymphocyte antigens class I antigens (Huet et al.,  1980). It 
is not at all clear that one type of noncoated vesicle is in- 
volved in the endocytosis of all of these molecules. 
Caveolae located abundantly on the surface of certain con- 
tinuous vascular endothelium may be involved not only in 
fluid-phase  and  receptor-mediated  endocytosis  but  also 
transcytosis (for review see Schnitzer, 1993). Binding sites 
and in some cases specific proteins have been identified on 
the endothelial cell surface that appear to be responsible for 
receptor-mediated transcytosis of a variety of blood-borne 
ligands including insulin (King and Johnson,  1985) and the 
carrier proteins, transferrin (Wagner et al.,  1983; Jeffries et 
al., 1984) and albumin (Schnitzer and Oh, 1994). Native and 
modified albumins bind the cell surface (Schnitzer et al., 
1988; Schnitzer and Bravo, 1993) via distinct receptor pro- 
teins  (Schnitzer  et  al.,  1992;  Schnitzer  and  Oh,  1994). 
Modified albumins  bind  gp30  and  gpl8  and are  internal- 
ized for degradation (Schnitzer and Bravo,  1993). In con- 
trast, native albumin, acting as a carrier for fatty acids and 
other small ligands (Galis et al.,  1988), binds albondin for 
caveolae-mediated delivery across the cell to the underlying 
tissue cells (Milici et al.,  1987;  Schnitzer and Oh,  1994). 
Anderson et al. (1992) propose that caveolae also participate 
in a different form of transport called potocytosis wherein 
small molecules bind to receptors which localize within cav- 
eolae to create a specialized environment with a high ligand 
concentration that  facilitates  its  transmembrane  transport 
directly into the cytoplasm by distinct protein channels. 
Caveolae are found most abundantly in certain endothelia 
of the continuous type but are also found to varying degrees 
in many, if not all, cell types including fibroblasts, adipo- 
cytes, and muscle cells. Cholesterol is a very important com- 
ponent of caveolae that appears to be required to maintain 
the structural integrity of this vesicular complex. At equilib- 
rium, the plasmalemma contains about 90 % of the total cho- 
lesterol found in many cells. Caveolae disappear in cells that 
are depleted of cholesterol and exposure of cells to sterol- 
binding agents such as filipin preferentially removes choles- 
terol from the plasmalemma which causes disassembly of 
caveolae and  unclustering of receptors found in  caveolae 
(Rothberg et al.,  1990 and  1992).  Most endothelia of the 
continuous type contain a very abundant population of cav- 
eolae that have been implicated in the endocytosis or transcy- 
tosis  of select macromolecules (for review see Schnitzer, 
1993). Although many recent studies provide support for a 
role of caveolae in transport, this function, especially for en- 
dothelium, has remained controversial, at least in part be- 
cause there has not been any way to selectively inhibit this 
pathway.  Therefore, based on this information, we decided 
to examine the effects of exposing endothelium to filipin on 
the cell surface density of caveolae and on their putative 
1. Abbreviations used in this paper: BAEC, bovine aortic endothelial cells; 
BLMVEC, bovine lungs microvascular cells; LDL,  low-density lipopro- 
tein; PS, permeability-surface area; RFC, rat epididymal fat pads. 
function in endocytosis and transcytosis both in situ and in 
vitro. 
Materials and Methods 
Materials 
Reagents and other supplies were obtained from the following sources: 
FCS, and PBS from GIBCO-BR (Grand Island, NY); gelatin from Difco 
Laboratories (Detroit,  MI);  crystallized BSA and  [14C]inulin  from ICN 
Biochemicals  (Cleveland,  OH);  filipin,  nystatin,  digitonin,  FITC  con- 
jugated BSA, bovine insulin,  and ovalbumin from Sigma Chemical (St. 
Louis, MO); DME from Irvine Scientific (Irvine, CA); Iodogen (1,4,5,6- 
tetrachloro-3a,6a-diphenylglycouril),  Triton  X-100,  BCA  protein  assay 
from Pierce Chemical Co.  (Rockford, IL); Nal25I from Amersham Corp. 
(Arlington  Heights,  IL);  ~2-macroglobulin from Boehringer-Mannheim 
Biochemicals (Indianapolis, IN); 14C-labeled BSA from Du Pont/New En- 
gland Nuclear (Boston, MA); Kodachrome, Kodacolor, and Tri-X Pan films 
from Eastman Kodak (Rochester, NY)  and all tissue culture plasticware 
from Costar Corp.  (Cambridge, MA) or Corning (Wilmington, DE). 
Cell Culture 
Microvascular cells, derived from rat epididymal fat pads (RFC) and bovine 
lungs microvascular (BLMVEC), along with bovine aortic endothelial cells 
(BAEC) were obtained, grown in culture, and tested periodically for en- 
dothelial markers as in our past work (Schnitzer, 1992; Schnitzer and Oh, 
1994;  Schnitzer et al.,  1994). 
Albumin Probes 
As described and characterized previously (Schnitzer et al.,  1992),  BSA 
was modified in the following ways:  (a) conjugation to 5-10-nm colloidal 
gold particles (A-Au); and (b) maleic anhydride treated (MaI-BSA). These 
probes along with native, unmodified BSA were radioiodinated using Iodo- 
gen as in our previous work (Schnitzer and Pinney,  1992). 
Surface Binding Assay 
Binding assays were performed as described previously (Schnitzer et al., 
1988a;  Schnitzer and  Pinney,  1992).  Briefly,  confluent cell  monolayers 
grown on 6-well trays were washed extensively, incubated for 10 rain with 
filipin in DME or DME alone, and then incubated for 20 rain at 4°C with 
1251-labeled BSA, 125I-labeled A-Au or t25I-labeled Mal-BSA in DME. Af- 
ter washing (3  ×  1 min) with ice-cold DME, the cells were lysed using 5 % 
Triton X-100 and 1% SDS, scraped from the wells, and then pipetted into 
vials for counting of radioactivity using a Beckman Gamma 5500B.  Dupli- 
cate wells were  run  for each concentration used.  Specific binding was 
quantified and final calculations were performed as in Schnitzer and Pinney 
(1992). 
Cell-associated Binding, Uptake, and Degradation 
Assay at 37°C 
As per our past protocol (Schnitzer and Bravo,  1993), confluent BLMVEC, 
RFC, and BAEC monolayers were washed extensively before incubation at 
37°C for various times with 125I-ligand. For insulin degradation studies, 
the BLMVEC were kept in DME without fetal calf serum at 37°C for 1 h 
before starting the assay. At specified times, all of the media from each well 
was removed and saved. The cells were immediately washed with ice-cold 
DME, lysed, and counted for radioactivity as described above. The media 
saved from each well was subjected to 10% TCA precipitation to determine 
the extent of ligand degradation. As shown in Schnitzer and Bravo (1993), 
the TCA-soluble counts were degradation products from cellular processing 
of the radioactive ligand whereas the TCA insoluble counts (pellet) repre- 
sented the undegraded ligand remaining in the medium. 
Fluorescence  Microscopy 
Washed BLMVEC grown on gelatin-coated glass coverslips were incubated 
at 37°C for 10 min with DME plus 1 mg/ml BSA as the control or DME 
plus BSA supplemented with the potential inhibitor (1-5 t~g/ml of filipin or 
1 mg/ml MaI-BSA).  Then,  this media was removed and replaced with 
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30 min the cells were washed (3x  ice cold DME for 1 min) and fixed in 
4% paraformaldehyde in PBS for 1 h. The coverslips with the cells were 
mounted on a glass slide and then were examined with a Zeiss Axiophot 
fluorescence microscope set for the appropriate excitation/emission viewing 
and photography (Kodachrome, Kodacolor, and/or Tri-X Pan films). 
Electron Microscopy 
After incubation with A-Au for 5, 10, 30 min at 37°C, confluent BLMVEC 
and BAEC monolayers were washed, fixed, and processed on the 35-ram 
plastic dishes for standard transmission  electron microscopy as in our previ- 
ous work  (Schnitzer et  al.,  1988a).  Other  BLMVEC  monolayers were 
treated with filipin at 5/~g/mi in DME for 0 to 60 min before processing 
for electron microscopy. The cell surface density of caveolae for untreated 
and treated BLMVEC was assessed quantitatively as in Schnitzer et al. 
(1994a). Some BLMVEC (control and filipin treated) were incubated with 
A-Au before processing for electron microscopy. 
In Vitro Transport across Endothelial Cell Monolayers 
As in our previous work (Schnitzer and Oh, 1994), BLMVEC seeded onto 
Transwell  filters  were  used  to  measure transport  across confluent cell 
monolayers.  125I-labeled  insulin,  125I-labeled  BSA  and  [14C]inulin  were 
used as  probes  to  assess transport  across BLMVEC  monolayers either 
treated or untreated with filipin in DME for  10 min at 37°C. 
Transport and Permeability Measurements in the Rat 
Lung In Situ 
The capillary permeability of BSA in the rat lung was assessed as in our 
past  work  (Schnitzer and  Oh,  1994).  The  tissue uptake of 1251-labeled 
A-Au, 125I-labeled BSA,  t4C-labeled BSA, and [14C]inulin  was measured 
similarly by perfusion through the pulmonary artery except that a  3-rain 
perfusion of radiolabeled  tracer was used instead of a  2-min perfusion. 
Briefly,  for all tracers, the lung vasculature was flushed for 3 min with oxy- 
genated Ringer's solution containing 30/~M of nitroprusside, for 90 s with 
Ringer's solution with or without filipin, for 3 min with radioactive tracer 
in Ringer's, and then for 3 min with Ringer's. Rat lung tissue samples were 
weighed and  measured for  radioactivity  so that transport  and  capillary 
permeabilities could be calculated and compared with control  lungs not 
treated with filipin. 
Results 
Examination of  Modified Albumin Endocytosis in 
Cultured Endothelial Cells 
Recently, we provided evidence that gp30 and gp18 mediate 
the avid binding,  internalization,  and degradation of mod- 
ified albumins (Schnitzer et al.,  1992; Schnitzer and Bravo, 
1993);  however,  the intracellular mechanism and pathway 
for the processing of these ligands remains unclear. Here, we 
first examined the kinetics of the binding,  endocytosis and 
degradation of modified albumins by cultured monolayers of 
BLMVEC and BAEC. The BLMVEC are advantageous be- 
cause relative to other endothelial cells,  they have a  more 
abundant population of caveolae (Schnitzer et al., 1994) and 
interact more avidly with modified albumins.  We then fo- 
cused on A-Au as a typical modified albumin probe to assess 
its subcellular distribution and movement between specific 
intracellular compartments. 
Analysis of Surface Binding,  Internalization, and Deg- 
radation  of Modified Albumins.  Modified albumin bind- 
ing to the surface of BLMVEC and BAEC was assessed at 
4°C  using  confluent monolayers that were incubated with 
~25I-labeled A-Au  or  ~25I-labeled Mal-BSA.  Cellular  pro- 
cessing of these ligands was also assessed at 37°C to evaluate 
uptake and degradation (see Materials and Methods).  Be- 
cause  the  observed  surface  binding,  internalization,  and 
degradation profiles were very similar to our past findings 
using the RFC cell monolayers (Schnitzer and Bravo, 1993), 
we report here only the significant differences which were: 
(a) a  slightly slower equilibration time for BLMVEC and 
BAEC surface binding of ~2SI-labeled A-Au and t25I-labeled 
Mal-BSA which required 30-40 min in comparison to the 
20-30  min  necessary  for  the  RFC  monolayers  (data  not 
shown); and (b) a larger capacity (approximately fivefold) of 
high affinity binding sites for the BLMVEC with a greater 
affinity (-5-10-fold) than the RFC  cells. Fig.  1 shows the 
Scatchard analysis of the high affinity binding of MaI-BSA. 
The  apparent  equilibrium  binding  constant  (Ks)  for  the 
higher affinity binding was 5.7 nM (0.38/zg/ml) with a maxi- 
mum  number  of binding  sites  (Bmax) of  63  ng/106 cells 
(570,000 binding sites/cell or 65/zg/m2). Scatchard analysis 
of ~25I-labeled A-Au  binding  also  revealed higher  affinity 
binding  with  a  Kd  of  15  nM  (1.0 /zg/ml),  about  fourfold 
more than that for the RFC cells. We also examined BAEC 
monolayers and  found,  relative to the  BLMVEC,  similar 
high affinity binding with about a twofold decrease in Bm~. 
In addition to possible variations among species and in mor- 
phological differences between the cells including cell sur- 
face densities of caveolae (Schnitzer et al.,  1994a), our use 
of bovine albumins in all of the binding experiments may 
provide at least a partial explanation for the greater affinities 
and number of binding sites of the bovine cells in comparison 
with the rat cells. 
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Figure 1. High affinity binding of modified albumins to BLMVEC. 
Confluent BLMVEC monolayers were assayed for surface binding 
of Mal-BSA (see Materials and Methods). The data was analyzed 
using a Scatchard plot.  The ratio of bound  to free Mal-BSA is 
presented on the ordinate axis while the abscissa presents the total 
specific bound Mal-BSA.  The linear regression equation for the 
high affinity binding after subtraction of the moderate affinity bind- 
ing component is Y =  16.64 -  0.263  x  (R  2 = 0.995). Each point 
represents the mean of multiple observations (6 >/~  2) with stan- 
dard deviations given as error bars for both axes. 
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Schnitzer et al. Filipin Inhibits  Caveolae-mediated  Transport  1219 Figure 2. Electron microscopy of cellular processing of A-Au. BLMVEC monolayers were washed and incubated at 37°C with A-Au for 
5,  10, or 30 min in the presence of 1 mg/ml of BSA in DME. After washing, the monolayers were processed  and sectioned for electron 
microscopy. (A, B, and F) 5 min A-Au incubation. A-Au detected within noncoated pits (np), apparently in the initial stages of forming 
caveolae and at the introit of formed noncoated plasmalemma vesicles (pv), possibly restricted by vesicle diaphragms.  The forming plas- 
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Number examined  Number with A-Au  Percent with A-Au  A-Au/vesicles  A-Au//~m*  Enriched  :.t 
Caveolae  342  133  39  3.8  9.8  9.0 
Coated vesicles  22  1  4.5  .09  .39  .36 
BLMVEC were incubated with A-Au  for 5-10 min and processed for electron microscopy.  Random  pictures of each sample were taken in 20 different cells. We 
examined 110/.,m of luminal-equivalent cell surface membrane (non-plastic side) and counted invaginated vesicles as in Schnitzer et al. (1994). 
* Average number of A-Au detected per total membrane length for total vesicles examined. 
Relative to examination of plasmalemma proper (no invaginations) which revealed I. 1 A-Au//~m. 
Electron Microscopy.  The cellular processing of A-Au at 
37°C was examined by standard electron microscopy. Fig. 2 
shows typical results demonstrating the endocytosis of A-Au 
by noncoated plasmalemma vesicles. After just 5-min incu- 
bation of A-Au with the cells at 37°C, most of the A-Au is 
located at the cell surface with small levels of accumulation 
within  apparent  endosomes  inside  the  cell  (range  of  1-5 
A-Au per occupied endosome; most endosomes were unoc- 
cupied). Noncoated vesicles with A-Au can be found on the 
cell surface in various stages of invagination from noncoated 
pits  to  fully  formed,  flask-shaped plasmalemma  vesicles. 
The A-Au is found: (a) as single particles on the outer sur- 
face of the diaphragms of clearly formed caveolae (one to 
two gold particles per diaphragm); (b) as clusters of three to 
seven  particles  not usually  attached  to  each other as  ag- 
gregates  but  attached  individually  to the  cell  surface,  all 
within small "dimples"  in the membrane that could be non- 
coated pits  forming noncoated plasmalemma vesicles;  (c) 
within  a  subset  of fully  formed  noncoated plasmalemma 
vesicles which are either attached directly to the cell surface 
or adjacent to the plasmalemma within 1,000A; and (d) as 
random  solitary  particles  on  the  plasmalemma  proper. 
Larger numbers of A-Au were found in noncoated pits than 
in fully formed plasmalemma vesicles. The large size of the 
A-Au and the small radius of the introit to the vesicles ap- 
pears to prevent easy access to fully formed, flask-shaped 
vesicles, especially those with diaphragms. A similar profile 
is observed when A-Au is interacted with the cells for 30 min 
at 4°C including: (a) solitary gold particles on the cell sur- 
face and the outside of vesicle diaphragms; and (b) very few 
formed  caveolae  containing  more  than  one  gold  particle 
(data not shown). With longer incubations of 10 min at 37°C, 
more  caveolae  with  many  more  gold  particles  (>--5) are 
found, suggesting that, if this accumulation and clustering of 
A-Au within vesicles is a dynamic process, then vesicles may 
have formed from the noncoated pits in this time frame. Af- 
ter  a  10-min incubation,  multivesicular bodies and  endo- 
somes contain not only A-Au more frequently but also much 
more A-Au than detected after just a 5~min incubation with 
the cells.  At 30-min incubation, there is ample A-Au visible 
within small to large endosomes, multivesicular bodies and 
lysosomes.  Quantitative  analysis  of the  A-Au subcellular 
distribution indicates that after short exposure times, A-Au 
is associated primarily with the cell surface, especially cav- 
eolae, and with longer incubations is progressively delivered 
to  endosomes,  multivesicular  bodies  and  lysosomes  (see 
Fig.  7). 
At all time points, coated pits and vesicles contain A-Au 
infrequently and when labeled,  only one to two particles 
were found. Fig. 2 E shows a typical coated vesicle without 
A-Au. Table I shows our quantitative analysis of the interac- 
tion of A-Au with the cell surface and its invaginated coated 
and noncoated vesicles.  In examining each distinct vesicle 
population  as  a  whole,  we  find  significant enrichment  of 
nearly 10-fold for A-Au localization to caveolae relative to 
the plasmalemma proper whereas almost a threefold decre- 
ment in relative binding to coated vesicles is noted.  Direct 
comparison of vesicular  types  shows  about  25-fold more 
A-Au binding to caveolae than to coated vesicles. Because 
a significant portion of the caveolae do not appear to interact 
with A-Au, there may be differences in caveolae so that sub- 
populations of caveolae may exist.  If so,  then the  surface 
binding density for that subpopulation reactive with A-Au is 
actually greater than that for the general population. With a 
density of about 25 A-Au/#m, the enrichment found in these 
select caveolae relative to the plasmalemma proper would in- 
crease from 10- to nearly 25-fold. Regardless of mathemati- 
cal manipulation, it is clear that A-Au preferentially interact 
with caveolae. 
It is curious to note that we found less A-Au at the cell sur- 
face after a 30-min incubation than a 10-min incubation even 
though these studies  were not "warm-up" protocols but con- 
stant 37°C incubations. This observation suggests the possi- 
bility that the A-Au receptors and/or the vesicular carriers 
may be diminished at the cell surface after ligand internaliza- 
tion. A-Au binding could initiate  a strong vectorial transport 
of itself into  the  cell  with  slow  recycling of the  vesicles 
and/or A-Au receptors back to the cell  surface.  Unfortu- 
nately,  we cannot definitively  address this issue until mono- 
specific  antibodies  are  produced to  the  surface  receptors 
malemma vesicles have several A-Au particles, many of which are bound next to the cell membrane. A-Au in pv not directly attached 
to the cell membrane is noted. Generally, pv contain one to two A-Au particles. Possible initial stages of pv fusions with forming early 
spherical endosomes (see F). The pv appear to be docking with larger vesicle, possible early endosome. (C and D) 10 min A-Au incubation. 
More extensive accumulation of A-Au in formed plasmalemma vesicles at cell surface (See C) and apparently within cytoplasm (see D) 
with many A-Au/vesicle. (E)  10 min A-Au incubation. Represents typical coated vesicle without A-Au. (G)  10 min A-Au incubation. 
Multivesicular body (mvb) studded with A-Au. Note many A-Au associated with internal vesicles. This micrograph represents most A-Au 
seen in mvb at this time point. (H and/) 30 min A-Au incubation. Very extensive accumulation of A-Au within multivesicular bodies 
(H) and lysosomes (I).  Bars, 0.2 #m. 
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ever, notice in the 30-min incubations that the plasmalemma 
directly adjacent to small and large endosomes containing 
ample A-Au was in almost all cases devoid of caveolae. This 
was  not true  for the  cell  membrane  "above" empty  endo- 
somes found in cells exposed for 5 or  l0 min to the A-Au 
and  many  endosomes  found  in  cells  not  incubated  with 
A-Au. Our observations suggest that:  (a) caveolae contain- 
ing A-Au can detach from the cell surface and deliver their 
contents to endosomes; (b) A-Au binding may initiate vesi- 
cle formation and rapid detachment of vesicles from the cell 
surface for vectorial delivery to endosomes;  and  (c) these 
vesicles  with  their  A-Au  receptors  may  not  be  recycled 
quickly from the endosomes back to the cell  surface. 
Sterol Binding Agents Reversibly 
Inhibit Caveolae-mediated  Endocytosis 
and Degradation 
Filipin is a macrolide pentene polyene antibiotic,  a class of 
drugs that binds sterols such as cholesterol (Bolard,  1986) 
and can disrupt caveolae in fibroblasts and smooth muscle 
cells (Severs and Simons, 1986; Rothberg et al.,  1990; Davis 
and Shivers,  1992). It is now clear that endothelial cells can 
endocytose and degrade modified albumins  apparently  via 
specific  interaction  with  gp30  and  gpl8  (Schnitzer  and 
Bravo,  1993) and that this  scavenger endocytosis is  medi- 
ated by caveolae (see above).  BLMVEC have an abundant 
population of caveolae (Schnitzer et al.,  1994) of which a 
subpopulation avidly endocytose modified albumins for deg- 
radation  and  apparently  others  transport  native  albumin 
transcellularly (Schnitzer and Oh,  1994). Therefore, we de- 
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Figure 3. Filipin reduces the cell surface density of noncoated plas- 
malemma  vesicles.BLMVEC  monolayers  were  treated  with  5 
#g/ml of filipin in DME for the indicated times, processed, and ex- 
amined by electron microscopy for quantitation  of cell surface den- 
sity of caveolae  as described previously (Schnitzer  et al.,  1994). 
The results are given as a mean value with a standard error bar for 
both the density of caveolae (number per/~m (left Y-axis)) and the 
percentage of the zero time point (right  Y-axis). 
cided to investigate the possible effects of filipin on caveolae 
and their processing of modified albumins. 
Filipin Reduces BLMVEC Surface Density of Caveolae. 
Confluent BLMVEC were incubated with filipin and exam- 
ined by electron microscopy to assess caveolae density at the 
cell surface. Fig. 3 shows that filipin treatment of BLMVEC 
reduces the cell surface density of caveolae in a time depen- 
dent manner. Both 30- and 60-min incubations decrease the 
number of noncoated plasmalemma  vesicles per  length  of 
cell membrane by about 90%.  Even exposures as short as 5 
min result in about a 50 %  reduction.  The caveolae density 
at the zero time point agrees well with our previous results 
(Schnitzer et al.,  1994). 
Inhibition  of A-Au  Uptake and Degradation but Not 
Surface Binding. To assess biochemically filipin's effects on 
caveolae-mediated  processing,  BLMVEC  treated  or  un- 
treated  with  filipin were incubated with  ~25I-labeled A-Au. 
Fig.  4  shows a dose response curve illustrating  that filipin 
greatly inhibits both the internalization  and degradation of 
125I-labeled A-Au by BLMVEC  in a  concentration depen- 
dent manner. The A-Au associated with the cells after a 30- 
min incubation at 37°C was maximally decreased by 70%. 
Degradation of A-Au was decreased by a maximum of more 
than  80%.  A  concentration as low as 0.5 #g/ml decreased 
degradation by greater than 70% and was nearly as effective 
as  5  #g/ml.  The  effective inhibition  of caveolae-mediated 
processing at these concentrations  is  quite consistent with 
our morphological observations that caveolae begin to disas- 
semble in just minutes at 5  /zg/ml of filipin (see above). 
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Figure 4. Dose response curve for filipin inhibition  of endocytosis 
and degradation of A-Au. Confluent  RFC, BAEC, and BLMVEC 
monolayers in six-well trays were washed, preincubated  for 10 min 
at 37°C in DME containing the indicated  concentration of filipin 
or xylazine as a control, and then incubated  fo 30 min with 235I- 
labeled A-Au. After washing, the cells and media were processed 
as usual to determine the cell-associated  and -degraded A-Au (see 
Materials and Methods).  The results were normalized to the control 
without filipin.  They were quite  similar  for each endothelial  cell 
type and therefore,  were combined. Each point represents the mean 
of multiple observations  (4 < N <  11) with SD given as error bars 
(N =  2 for each xylazine  point). 
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from its direct interactions with the receptor and/or ligand 
so as to prevent cell surface binding, we tested the effects of 
filipin  on  A-Au  interaction  with  the  BLMVEC  surface. 
These  experiments  were  performed  by  preincubating  the 
cells with filipin for 10 min at 4°C or at 37°C before per- 
forming the usual binding assay~ at 4°C.  We found no evi- 
dence for interference with the bfttding. In fact, we observed 
a 25-50 % increase in detected binding with filipin treatment 
which is consistent with the possible unmasking of receptors 
normally found inside fully formed noncoated plasmalemma 
vesicles.  As  discussed  earlier  in  our  electron  microscopy 
studies, direct access of A-Au to fully formed plasmalemma 
vesicles may be limited so that filipin-induced flattening or 
"devagination" of the vesicles to the cell surface may cause 
more direct exposure of the  A-Au binding  sites.  Further- 
more, consistent with these results, we found that filipin does 
not affect direct A-Au binding of gp30 and gpl8 electrotrans- 
ferred onto nitrocellulose from gels after SDS-PAGE of cell 
lysates (data not shown). 
From these results, it would appear that at 37°C the 70% 
decrease  in  cell-associated A-Au after filipin treatment is 
consistent with a significant prevention of ligand endocytosis 
but not cell surface binding.  We have noted previously that 
about 25 % of A-Au associated with the cells at 37°C is nor- 
mally cell surface bound and sensitive to Pronase digestion 
whereas  at  4°C  greater  than  90%  is  Pronase  sensitive 
(Schnitzer  and Bravo,  1993).  When we performed similar 
experiments with filipin-treated cells, we found a significant 
increase  in  the  cell-associated A-Au that was  sensitive to 
Figure 5. Fluorescence microscopy of  processing of  A-Au. BLMVEC were incubated at 37°C for 30 min with DME containing FITC-A-Au 
and 1 mg/ml of either native albumin BSA (A) or the modified albumin Mal-BSA (B). After washing, the cells were fixed and processed 
for fluorescence microscopy (see Materials and Methods). In C, the cells were pretreated with filipin (5 #g/ml) before the addition of the 
FITC-A-Au. In D, immediately after the filipin treatment,  the cells were incubated in DME containing  10% FCS for 30 min to reverse 
the effects of filipin before examining FITC-A-Au processing. Note that in both B and C, the exposure time for the film was two to three 
times that for the control.  Bar, 30 #m. 
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formed at 4°C,  this Pronase sensitivity indicates a  lack of 
cellular uptake to a Pronase-protected compartment consis- 
tent with a predominant cell surface distribution. 
Fluorescence Microscopy.  The effect of filipin on the cel- 
lular processing was examined by fluorescence microscopy 
using  A-Au  made  from  FITC  conjugated  to  albumin 
(FITC-A-Au).  Fig.  5  shows that  incubation of BLMVEC 
with FITC-A-Au creates a punctate signal consistent with its 
accumulation in endosomes or lysosomes as shown earlier 
by electron microscopy. There are also finer punctate sig- 
nals, especially visible in the peripheral regions of the cells, 
which may represent clusters of A-Au within caveolae (also 
as  shown by electron microscopy). As expected from our 
radiobiochemical assays  (Schnitzer and Bravo,  1993),  the 
modified albumin MaI-BSA is an able competitor and pre- 
vents binding and internalization of the FITC-A-Au as indi- 
cated by the lack of signal on or in the cells (note that all ex- 
periments are performed in the presence of 1 mg/ml of BSA 
which is not inhibitory). With filipin treatment, both large 
and fine punctate signals disappear and a rather weak dif- 
fuse signal is apparent on the cell surface. There is little, if 
any, evidence for clustering, internalization, and accumula- 
tion of the probe which is quite apparent in the control. 
Electron Microscopy.  We have shown earlier that A-Au 
interacts preferentially with caveolae, resulting in endocyto- 
sis.  Here, we use electron microscopy to show directly that 
filipin inhibits this uptake by caveolae. Fig. 6 shows control 
and flipin-treated BLMVEC incubated with A-Au. Clearly, 
the number of caveolae is decreased tremendously and the 
A-Au associated with the cells is not found, as in the control, 
within caveolae at the cell surface or even inside the cells but 
bound only to the outside of the cell at the plasmalemma 
proper. Fig. 7 shows a graphical summary Of  our quantitative 
analysis performed on cells incubated with A-Au for 5 and 
30 min.  There is a signifcant difference in the subcellular 
distribution of A-Au processed by control and filipin-treated 
cells. After filipin treatment of the cells, A-Au interaction is 
limited to the cell surface with a very significant decrease in 
cellular uptake as indicated by a lack of A-Au found in cav- 
eola, endosomes and multivesicular bodies. After 5-min in- 
cubation of the BLMVEC with A-Au at 37°C, both treated 
and untreated cells have greater than 80% of the A-Au as- 
sociated with the cell surface. However, even at this early 
time point, there is a major difference in the distribution at 
the cell surface. For control cells, most A-Au is found as- 
sociated with caveolae attached to the cell membrane or un- 
derneath it; however, for the treated cells, A-Au is almost ex- 
clusively bound  to  the plasmalemma  proper with  only a 
small percentage of the total A-Au found in the few caveolae 
that remain after treatment.  Even at this early time point, 
significant reductions with filipin treatment are evident in 
delivery toendosomes and multivesicular bodies. Longer in- 
cubation  of the  cells  with  A-Au  to  30  min  extensively 
Figure 6. Electron microscopy of A-Au endocytosis by control and filipin-treated BLMVEC. BLMVEC exposed for 20 rain to DME alone 
(A) or DME plus 5 #g/ml of filipin (B) were incubated with A-Au in DME for 5 min, washed, fixed, and processed for electron microscopy. 
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Figure 7. Filipin's effect on A-Au processing by BLMVEC. Before 
incubation with A-Au for the indicated times, BLMVEC were ex- 
posed for 20 min to DME alone (control; solid line and symbols) 
or DME plus 5 ~g/ml of filipin (dotted line and empty symbols), 
and then fixed and processed for electron microscopy. Quantitative 
analysis of the subcellular distribution of A-Au was performed by 
counting and localizing each A-Au to the plasmalemma proper, 
caveolae, endosomes or multivesicular bodies/lysosomes (MVB). 
Results for each category are expressed as the mean percentage of 
the total cell-associated A-Au. 
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Figure 8.  Filipin reversibility and effect of other  sterol binding 
agents  on  A-Au degradation.  Confluent  RFC, BAEC, and 
BLMVEC monolayers in six-well trays were preincubated for 10 
min at 37°C in DME alone or containing 5 ~g/ml of filipin, nysta- 
tin,  or digitonin and then processed as in the legend of Fig. 2. 
Rev-filipin represents the degradation achieved after attempting to 
reverse the filipin effects  using a 30-min incubation of  the cells with 
DME plus 20% FCS as described in the text. The results were nor- 
malized to the controls without filipin. Each bar gives the percent- 
age of degradation detected in the control and represents the mean 
of multiple observations (2 ~< N~< 6) with standard deviations given 
as error bars. 
changes the distribution profile for A-Au associated with the 
control but not filipin-treated ceils. BLMVEC normally ac- 
cumulate  A-Au  within  endosomes,  multivesicular bodies 
and lysosomes (Fig. 7); however, with treatment, A-Au re- 
mains predominantly associated with the cell surface with 
greatly reduced levels of endocytosis and delivery to intra- 
cellular  compartments.  These  results  show  that  filipin- 
treated cells: (a) have fewer caveolae; (b) can still bind A-Au 
at the cell surface but in this case primarily to the plas- 
malemma proper and not caveolae; and (c) have a significant 
reduction in A-Au internalization. Our results to date indi- 
cate that filipin's ability to disassemble caveolae can indeed 
prevent the endocytosis and degradation of caveolae-specific 
ligands such as A-Au. 
Inhibitory Effect Is Reversible. We examined the reversi- 
bility of the effects of filipin treatment on the cells. BLMVEC 
monolayers treated with filipin for 15 min were washed',  in- 
cubated for 30 min in standard cell culture media containing 
20%  FCS and then processed through the usual assay ex- 
amining  A-Au  degradation.  Fig.  8  shows  that  this  short 
reversal treatment resulted in restoration of normal, if not 
slightly elevated, levels of A-Au degradation by the cells. 
Similar reversibility was also demonstrated by fluorescence 
microscopy (see Fig.  5 D). 
Other Cholesterol-binding  Agents Inhibit A-Au Degra- 
dation.  We  also  tested  other  sterol/cholesterol  binding 
agents.  Like  filipin,  nystatin  is  also  a  polyene antibiotic 
(Bolard,  1986)  whereas  digitonin  is  a  cardiac  glycoside 
(Elias et al., 1978). Both agents bind cholesterol and can re- 
move it from cell membranes. Fig. 5 shows that nystatin and 
digitonin inhibited A-Au degradation by more than 50 and 
85%,  respectively.  Other  agents  known  to  interact  with 
lipids in the cell membrane such as xylazine (see Fig. 4) and 
polymyxin B (data not shown) were ineffective. 
Inhibition  of a2-Macroglobulin Endocytosis  and Degra- 
dation.  Activated a2-macroglobulin is  internalized by re- 
ceptor-mediated endocytosis via clathrin-coated pits/vesi- 
cles (Dickson et al., 1981; Trans et al., 1987). Fig. 9 shows 
that under equivalent conditions, filipin inhibits significantly 
the endocytosis and degradation of A-Au by about 70% but 
does not reduce the uptake and degradation of methylamine- 
activated ct2-macroglobulin. These results suggest that the 
coated  vesicular  degradative  pathway  with  its  associated 
coated pits, vesicles, endosomes, and lysosomes is not detri- 
mentally altered by filipin. The compartments of this path- 
way are functionally intact,  unlike the early stages of the 
noncoated vesicular pathway. 
Partial Inhibition of Insulin Endocytosis but Not Degra- 
dation.  Insulin classically is thought to be internalized by the 
clathrin pathway but more recent evidence indicates that at 
least in endothelium it can be endocytosed by both clathrin- 
coated and noncoated vesicular pathways (Roberts and San- 
dra,  1992; King and Johnson,  1985).  Interestingly, Fig.  9 
shows that filipin partially prevents BLMVEC uptake of in- 
sulin by about 50%; however, insulin degradation is not di- 
minished. These results are consistent with past observations 
that coated pits internalize insulin for degradative purposes 
and that in endothelium, insulin can be internalized not only 
for degradation but also for other purposes such as transcy- 
tosis (King and Johnson,  1985;  Rabkin et al.,  1993). The 
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dation  of  various  macromolecules  by  BLMVEC  monolayers. 
Confluent  BLMVEC  monolayers  in  six-well  trays  were  prein- 
cubated for 10 min at 37°C in DME with  1 mg/ml of BSA (DBSA) 
or DBSA containing either  5 #g/ml of filipin or 1 mg/ml of unla- 
beled  ligand  (for  ~2SI-labeled A-Au,  Mal-BSA  was  used).  The 
cells  were  incubated  for  30-60  min  at  37°C  with  m25I-labeled 
ligands  (A-Au,  insulin,  or  methylamine-activated  c~2-macroglo- 
bulin  [Mac])  in  DBSA  supplemented  as  in  the  pre-incubation 
period, washed,  and then processed to assess cell association  and 
degradation  (see Materials and Methods).  The results were normal- 
ized to the controls (DME alone; untreated). Each bar gives the 
percentage of  degradation detected in the control and represents the 
mean of multiple observations  (3 ~< N ~< 6) with standard deviations 
given as error bars• 
filipin-resistant coated pits/vesicles could be responsible for 
insulin  endocytosis  and  degradation  whereas  caveolae, 
which disassemble after filipin treatment,  could internalize 
insulin  not for degradation  but ultimately  for transcytosis 
(see below). 
Filipin Inhibits Caveolae-mediated Transcytosis 
Endothelial cells form an attenuated monolayer lining blood 
vessels that in many tissues is the critical barrier controlling 
the transport of molecules from the blood to the interstitium 
harboring  the  tissue  cells.  Receptors  located  on  the  en- 
dothelial cell surface may play a very important role in the 
selective  delivery  of essential  nutrients  to  the  underlying 
tissue cells.  Receptors for carrier proteins such as transfer- 
rin,  albumin,  orosomucoid,  and  ceruloplasmin  have been 
defined kinetically through binding experiments and in some 
cases  specific  binding  proteins  have  been  identified  (for 
review see Schnitzer,  1993).  Other studies have shown that 
insulin receptors contribute signficantly to the transendothe- 
lial  transport  of insulin  by  demonstrating  that  antibodies 
recognizing insulin receptors on the endothelial cell surface 
inhibit not only insulin internalization but also its transport 
across  cultured  endothelium  (King  and  Johnson,  1985). 
Since endothelium can have a  very abundant population of 
caveolae, it has largely been presumed that these noncoated 
plasmalemmal vesicles mediated the transport of these select 
blood-borne macromolecules. Immunogold electron micros- 
copy has shown that endothelial caveolae mediate the trans- 
cytosis of albumin (Milici et al.,  1987). We recently have de- 
veloped a model for evaluating receptor-mediated effects on 
transendothelial transport in vitro and in situ and have shown 
that  antibodies  to  the  albumin  binding  protein,  albondin 
signifcantly  inhibit  the transcytosis  of albumin  (Schnitzer 
and Oh, 1994). BLMVEC form a monolayer when grown on 
filters  in  culture  that  exhibit  albondin-mediated  transen- 
dothelial transport of albumin.  Therefore,  in this study, we 
attempted to test the effects of filipin using this in vitro trans- 
port system and both albumin and insulin as specific probes 
for caveolae-mediated  transcytosis. 
Because  concentrations  as  low  as  0.5  /zg/ml  were  quite 
effective in preventing caveolae-mediated intracellular trans- 
port  of A-Au  by  BLMVEC,  we  tested  filipin's  effects  on 
transcellular transport at levels -<<1/~g/ml. Fig.  10 shows that 
both BSA and insulin transport was reduced in a manner de- 
pendent on filipin concentration. We also used an inert small 
solute probe, inulin (5,000-5,550 molecular weight), that is 
transported across endothelium paracellularly via intercellu- 
lar junction and is not expected to interact with the cell sur- 
face. Filipin at  1/zg/ml appears to reduce insulin and BSA 
transport by about 50-60 % while not affecting inulin trans- 
port.  We have previously shown that BSA transport across 
these monolayers was 50 % dependent on albondin binding 
and transcytosis whereas the remainder appeared to be inde- 
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Figure 10. Filipin inhibits the transport of insulin and albumin (but 
not  inulin)  across  confluent  BLMVEC  monolayers.  BLMVEC 
grown on Transwell filters were used to examine the effects of filipin 
at the concentration indicated on the transport of t25I-labeled BSA, 
125I-labeled insulin,  and [J4C]inulin across monolayers in vitro (see 
Materials and Methods).  The results were normalized to the control 
without filipin. Each point represents the mean of multiple observa- 
tions (4 ~< N~< 18) with a SD ~<20%. The asterisk  shows the mean 
normalized t25I-labeled BSA transport when assessed  in the pres- 
ence of excess  unlabeled  BSA (1  mg/ml).  The transport of m25I- 
labeled  insulin was reduced to 42 % of control in the presence of 
1 mg/ml of unlabeled  insulin. 
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by paracellular and/or  fluid phase mechanisms (Schnitzer 
and Oh, 1994). Others have shown that about 60 % of insulin 
transport across endothelial cell monolayers is inhibited by 
the interaction of antibodies with the insulin receptor and 
therefore, is dependent on cell surface binding and receptor- 
mediated transcytosis. It would appear that ablation of cav- 
eolae with filipin can inhibit the specific transcytosis of both 
albumin and insulin at levels that are quite consistent with 
past  in  vitro  findings.  Filipin  does  not  appear  to  affect 
paracellular transport. 
Filipin  can  reduce  transport  by  60%  which  is  nearly 
equivalent to the effect elicited by low temperatures which 
minimize  vesicular  transport  and  only  allow  paracellular 
transport (Schnitzer and Oh,  1994). When the experiments 
are performed at 4-8°C, filipin does not further reduce trans- 
port in vitro and, as in the case for A-Au discussed above, 
it  does  not  reduce  surface  binding  of albumin  (data  not 
shown). These findings are consistent with filipin inhibiting 
a  temperature-sensitive  transcytotic  component while  not 
affecting paracellular transport. 
Filipin Inhibits Caveolae-mediated but Not 
Paracellular Transport In Situ 
So far, all our studies have focused on cultured endothelial 
cell monolayers in vitro. Therefore, we extended the testing 
of filipin by evaluating its effect on transport in situ. 
Inhibition of Capillary Permeability of Albumin in the 
Rat Lung In Situ.  First,  we tested for possible effects of 
filipin in situ by examining albumins permeability in the rat 
lung  vasculature by pulmonary artery perfusion as deter- 
mined in our past work (Schnitzer and Oh,  1994).  Fig.  11 
shows  that  filipin  was  very effective in  a  dose-dependent 
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Figure I1.  Filipin lowers capillary permeability  to albumin in the 
rat lung. The capillary permeability of ~25I-labeled BSA was mea- 
sured in situ in rat lungs treated with filipin at the indicated concen- 
tration  (see  Materials  and  Methods).  The permeability-surface 
area product (left ordinate and open circles) and the percent inhibi- 
tion of t25I-labeled  BSA transport (right ordinate and solid circles) 
are presented.  Each point with SD given as error bars represents 
the mean of multiple observations from 28 or more tissue samples 
(28 ~< N ~< 42) from at least two rats. 
manner in reducing the transcapillary transport of albumin 
and the calculated capillary permeability-surface area (PS) 
product for albumin. The PS product for albumin attains a 
maximum reduction  of 50-60%  at concentrations  greater 
than or equal to 0.3 #g/ml. It should be noted that with filipin 
treatment, we did not observe any changes in hemodynamic 
parameters such as vascular resistance, perfusion pressures 
and flows nor any evidence for edema formation as indicated 
by water content per gram of tissue. It was not surprising un- 
der the harsher conditions inherent to the transport assays in 
situ with convective hydrodynamic flow and pressure gra- 
dients  that  the  transport  observed  was  more  sensitive to 
filipin than in the studies in vitro.  The maximal effect was 
achieved with much shorter exposure times and about two- 
fold lower concentrations. At least part of the explanation for 
this increased sensitivity in situ probably relates to the inher- 
ent diffusive nature of the system in vitro versus the higher 
pressure and convective nature of vascular perfusions in situ. 
Selective Inhibition of Tissue Uptake in the Rat Lung In 
Situ.  The tissue uptake after vascular perfusion of various 
probes was also examined in the rat lung in order to test vari- 
ous endothelial cell transport pathways in situ. Inulin is small 
enough  to  be  transported  paracellularly  across  the  en- 
dothelial barrier via intercellular junctions while A-Au was 
used to assess caveolae-mediated endocytosis. Fig. 12 shows 
that filipin inhibited the tissue accumulation of A-Au, BSA 
(both  n25I-labeled and  ~4C-labeled)  but not inulin  in the rat 
lung after perfusion via the pulmonary artery. A-Au trans- 
port was reduced by 60 %. In agreement with the studies per- 
formed  in  vitro,  filipin  effectively  inhibits  the  caveolae- 
mediated pathways in situ including  both transcytosis and 
endocytosis without affecting paracellular transport via in- 
tercellular junctions. 
Membrane Permeabilization at Higher Filipin  Concen- 
trations. At sufficiently high concentrations and long enough 
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Figure 12. Selective inhibition of capillary transport in rat lung in 
situ.  The endothelial  transport  of [z4C]inuliu, ~2~I-labeled BSA, 
~4C-labeled BSA, and 125I-labeled  A-Au were assessed in rat lungs 
either untreated  (blank bars) or treated with 0.3 /zg/ml of filipin 
(hatched bars). The results were normalized to the control without 
filipin. Each bar represents the mean of multiple observations (6 ~< 
N ~< 28) with the SD given as an error bar. 
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nystatin are well-known for their ability to permeabilize cells 
by disrupting the plasmalemma. When we increased by sev- 
eral-fold the  exposure times and  concentrations of filipin 
used in our in situ and in vitro assays, we also found evidence 
for sufficient cell membrane permeabilization that the over- 
all transport observed was greatly increased. With  10-fold 
increases over the optimum conditions described above, both 
inulin and albumin transport increased many times over the 
control. In situ perfusions at higher concentrations also re- 
suited  in  significant  edema  with  large  increases  in  lung 
weight and percent water weight (data not shown). 
Discussion 
Specific vesicular transport  of macromolecules is  a  fun- 
damental cellular process that is well documented in a vari- 
ety of cells for intracellular trafficking, receptor-mediated 
endocytosis, and to a lesser extent transcytosis. At least two 
morphologically distinct types of vesicles exist on the cell 
surface of many cells, albeit in disparate proportions ranging 
from cells such as hepatocytes with a plethora of  coated vesi- 
cles/pits and few noncoated ones to many endothelia with an 
abundance  of noncoated  plasmalemma  vesicles  and  few 
coated vesicles. Even endothelia in different tissues have a 
wide spectrum of distributions of these vesicles with most 
endothelia of the continuous type having many caveolae and 
few coated vesicles (except for brain where both types are 
underrepresented) whereas sinusoidal endothelia have many 
coated vesicles with noticeably fewer noncoated ones. Non- 
coated plasmalemmal vesicles and caveolae are interchange- 
able terms for the same structure. By electron microscopy, 
they appear in many cells types as invaginated pits or vesicles 
that do not have a thick electron-dense fuzzy coat (distinct 
for coated vesicles) but have a uniform diameter of about 
800-1,000/~.  In some cells, much larger noncoated plas- 
malemma vesicles have been described (Oliver,  1982).  In 
other cells, especially endothelium, many individual non- 
coated plasmalemma vesicles exist but also several vesicles 
can be connected to each other in a stringlike fashion form- 
ing a racemose, treelike vesicular structure. 
Caveolae-mediated Scavenger  Endocytosis 
When ligands such as LDL and albumin are modified to cer- 
tain nonnative states, they interact selectively with a new set 
of cell surface proteins called scavenger receptors that medi- 
ate endocytosis of these aberrant proteins (Brown and Gold- 
stein,  1983;  Sparrow et al.,  1989;  Schnitzer et al.,  1992; 
Schnitzer and Bravo, 1993). As a group, scavenger receptors 
bind proteins that have been modified appropriately by a va- 
riety of means such as oxidation, nonenzymatic glycation, 
acetylation, maleylation, or even surface adsorption. Scav- 
enger endocytosis of modified but not native proteins appear 
to serve a protective function necessary to maintain local tis- 
sue integrity by removing old, damaged, or possibly delete- 
rious proteins for selective degradation or catabolism (Stein- 
berg et al., 1989). Such scavenging may remove proteins that 
become damaged within tissues by either normal aging or 
protective or pathological responses such as oxidation dur- 
ing  inflammation  or  hyperglycation in  diabetes.  Binding 
to scavenger receptors is classically thought to initiate li- 
gand internalization via endocytotic mechanisms involving 
clathrin-coated plasmalemmal vesicles (Pitas et al.,  1985; 
Mommaas-Kienhuis et al.,  1985). In this study,  we demon- 
strate a novel filipin-sensitive pathway for the scavenger en- 
docytosis of modified protein involving caveolae. Our elec- 
tron  microscopy  studies  show  that  modified  albumins 
preferentially interact with endothelial caveolae. They are in- 
ternalized, not by coated vesicles, but almost exclusively by 
caveolae, and are then shuttled through a series of early to 
late endosomes to multivesicular bodies and lysosomes. 
It is now becoming clear that modified albumins such as 
A-Au  can be internalized via either coated or noncoated 
vesicles depending on the cell type. Very recently Faustmann 
et al. (1992) showed that subarachnoid macrophages endocy- 
tose A-Au via coated vesicles. In situ studies in liver, bone 
marrow, and adrenal tissue, which have microvascular beds 
lined with a  noncontinuous type of endothelium with few 
caveolae, showed that coated vesicles mediate A-Au endocy- 
tosis (Geoffrey and Becker,  1984;  De Bruyn et al.,  1985; 
Bumbasirevic  et  al.,  1990).  However,  in  other  vascular 
beds with a continuous endothelium (lung, heart, and dia- 
phragm),  modified albumins  such  as  glycated  A-Au  can 
bind within caveolae and in some cases, accumulation within 
lysosomes has been noted (Villaschi et al.,  1986; Predescu 
et al.,  1988). Like coated vesicles (Bretscher et al.,  1980), 
noncoated vesicles appear to have the ability to act as a mo- 
lecular filter that screens the endocytosis of select molecular 
cargo. 
Albumin Receptors and Caveolae-mediated 
Transcytosis vs. Endocytosis 
Three cell membrane-associated albumin binding proteins 
called albondin, gp30 and gpl8 have been identified (Schnit- 
zer et al.,  1988b; Ghinea et al.,  1988;  Schnitzer and Oh, 
1994);  however, more recent studies  indicate that two of 
these proteins, gp30 and gpl8, actually interact much more 
avidly with modified albumins including A8-Au  than with 
native albumin (Schnitzer et al.,  1992). Because albumin's 
native conformation is modified when it is absorbed to sur- 
faces such as colloidal gold particles (Schnitzer et al., 1992), 
A-Au is not an equivalent probe for native albumin.  The 
binding behavior of gp30 and gpl8 closely resembles that of 
other known scavenger receptors (Schnitzer et al.,  1992). 
Conversely, albondin, formerly named gp60, interacts with 
native albumin  (Schnitzer and Oh,  1994)  and appears to 
share  a  common  albumin  binding  domain  with  another 
known albumin binding protein, SPARC (Schnitzer and Oh, 
1992). Antibodies specific for albondin inhibit cell surface 
binding and internalization of native but not modified albu- 
mins  by  BLMVEC.  Moreover,  anti-albondin  antibodies 
along  with  unlabeled  native  but  not  modified  albumins 
significantly inhibit radiolabeled albumin transport across 
lung microvascular endothelium both in situ and in culture 
(Schnitzer and Oh,  1994). 
Although both native and modified albumins can be inter- 
nalized by caveolae, only modified albumins are directed pri- 
marily to endosomes and lysosomes for degradation (Schnit- 
zer and Bravo, 1993; Schnitzer and Oh, 1994). Studies done 
in situ show that continuous endothelium transport "native" 
monomeric albumin across the cell via caveolae without evi- 
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al.,  1987; Ghitescu and Bendayan,  1992).  The  extent of 
specific transcytosis of modified albumins such as A-Au re- 
mains  controversial.  In  the  murine lung,  Ghitescu et  al. 
(1986)  have observed transcytosis of A-Au with some ac- 
cumulation in endosomes. But in the rat lung, Villaschi et 
al.  (1986)  found little transport across the endothelium of 
surface bound A-Au with most of it eventually being found 
in endosomes and lysosomes. Herein, our electron micros- 
copy studies found caveolae-mediated endocytosis of A-Au 
directed to endosomes and lysosomes. Furthermore, our re- 
cent studies (Schnitzer et al.,  1992;  Schnitzer and Bravo, 
1993; Schnitzer and Oh, 1994) have shown that: (a) greater 
than 90 % of the modified albumin internalized by cultured 
endothelium is exocytosed degraded whereas greater than 
90%  of internalized native albumin is exocytosed in non- 
degraded form; (b) unlike their endocytosis and degradation 
which is strongly dependent on cell surface binding, mod- 
ified albumins such as Mal-BSA cross BLMVEC mono- 
layers in a  manner independent of cell surface binding by 
fluid-phase and/or paracellular transport; and (c) native al- 
bumin can be  transported transcellularly in  a  facilitative 
manner via its specific interaction with the cell surface pro- 
tein, albondin. 
Although at this time, it is unclear if the control of cav- 
eolae-mediated transport  is  dependent on  ligand binding 
to its receptor, our work shows that caveolae, like coated 
vesicles, can mediate scavenger endocytosis of conforma- 
tionaUy modified proteins for lysosomal degradation. Mod- 
ified albumins may bind via their receptors, gp30 and gpl8, 
to a select subpopulation of noncoated pits/vesicles that are 
involved in receptor-mediated endocytosis and degradation 
whereas native albumin may bind another set of vesicles 
mediating  transcytosis.  Alternatively,  modified  albumin 
binding could cause vesicles to follow a degradative pathway 
whereas the binding of native albumin to albondin results in 
transcytosis. Selective binding to each set of receptors may 
result in the clustering of ligand-receptor complexes and the 
formation of distinct vesicles destined for different sites in 
the cell. 
Selective Inhibition of Caveolae-mediated  Transport 
The effects of exposing endothelium to cholesterol-binding 
agents  are  quite  significant and  include  ablation  of en- 
dothelial caveolae and reduction of endothelial transcytosis, 
scavenger endocytosis and capillary permeability in a man- 
ner  that appears  to  be  quite  selective  for the  noncoated 
vesicular-mediated  pathways.  Filipin  treatment  of  endo- 
thelial cells both in vitro and in situ inhibits the intracellu- 
lar and transceUular transport of select macromolecules. The 
transport of two important blood proteins, namely insulin 
and albumin, are inhibited greatly. Native albumin is trans- 
cytosed via caveolae from the blood to the interstitium in 
many endothelia of the continuous type (Milici et al., 1987; 
Ghitescu and Bendayan, 1992), apparently through its inter- 
actions  with  albondin  (Schnitzer and Oh,  1994).  Filipin 
significantly reduces  albumin's  transendothelial  transport 
both in situ and in vitro. Albumins permeability in the rat 
lung vasculature is  reduced  significantly. Conversely, the 
paracellular transport of the small solute inulin is not af- 
fected in situ or in vitro. These results indicate that caveo- 
lae play an important role in the transport of  macromolecules 
circulating in the blood and that filipin can prevent caveolae- 
mediated transcellular transport without significantly dis- 
rupting paracellular transport. 
Intracellular transport mediated by caveolae can also be 
inhibited by filipin both in culture and in situ. Direct A-Au 
degradation studies performed in vitro show strong inhibi- 
tion with filipin, nystatin and digitonin. Filipin inhibits A-Au 
uptake and degradation in a dose-dependent manner. Many 
different experimental approaches show that filipin reversi- 
bly prevents A-Au internalization and delivery to endosomal 
and lysosomal compartments. Conversely, both morphologi- 
cal and functional studies indicate that the clathrin-coated 
vesicular pathway is not disrupted significantly by the treat- 
ment of the endothelial cells. Here, we show that the degra- 
dation of ligands of the coated vesicular endocytic pathway, 
insulin and activated ot2-macroglobulin,  is not affected by 
filipin treatment. Moreover, subcellular localization of  trans- 
ferrin receptors  (known  endogenous resident markers  of 
coated pits, vesicles, and early endosomes) is not altered in 
BLMVEC by filipin (our unpublished observations). Roth- 
berg et al. (1992) also provide evidence that cholesterol bind- 
ing agents disrupt noncoated vesicles but not coated vesicles. 
Just a 5-10 min treatment of fibroblasts causes almost total 
loss of noncoated vesicles on the cell surface with little effect 
on other membrane structures such as clathrin-coated pits. 
Sterol binding agents remove cholesterol from cell mem- 
branes and cause vesicle flattening from disassembly of the 
infrastructure of the caveolae (Rothberg et al., 1990, 1992). 
Using electron microscopy, we also describe a large decrease 
in the number of caveolae on the endothelial cell surface 
when BLMVEC are treated with filipin. The time course for 
the effect of filipin on endothelial cell caveolae is slightly 
longer (about 15-30 min) than observed for fibroblasts prob- 
ably because  of the  much greater density of caveolae in 
endothelium (at least 10-fold). Furthermore, our studies us- 
ing fluorescence and electron microscopy indicate that af- 
ter  filipin  treatment,  A-Au  is  located  diffusely over  the 
BLMVEC surface with little, if any, evidence of its internali- 
zation by caveolae and delivery to endosomes and lysosomes 
(see Figs. 3 and 4). Together,  our studies provide evidence 
that the coated vesicle-mediated degradation pathway,  in- 
cluding coated pits/vesicles, endosomes and lysosomes, re- 
mains sufficiently unaltered by filipin treatment to remain 
structurally and functionally intact. Conversely, our studies 
with A-Au and those of Rothberg et al. (1990) examining the 
5-methyltetrahydrofolate  receptor show that filipin treatment 
permits ligand binding at the cell surface but effectively pre- 
vents receptor clustering within caveolae. Filipin also in- 
hibits A-Au degradation by selectively preventing endocyto- 
sis through the noncoated vesicular pathway. 
Caveolae as Transport Structures 
Our knowledge about the standard mechanisms for the trans- 
port of molecular cargo from one compartment to another 
in the cell has evolved largely from studies examining the 
clathrin-coated vesicular pathways. This transport generally 
is thought to involve the dynamic "shuttling" of vesicles from 
one membrane surface to another. Vesicles form through the 
indentation of the  membrane  to  form a  "pit" which  in- 
vaginates further to create a "flask-shaped"  vesicle that even- 
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in the cytoplasm. Such vesicles can be delivered to a specific 
destination within the cell for membrane fusion and release 
of their contents by a specific set of targeting receptors and 
fusion proteins (Sollner et al.,  1993). For endocytosis and 
protein trafficking, it is clear that vesicles can deliver their 
discrete packages through a "shuttling" process. This is also 
probably true for at least some caveolae which appear to be 
able to deliver their cargo either to endosomes or across the 
cell to the opposite cell membrane surface.  Because this 
"fission-fusion" model of vesicular transport has held true 
for many different types of vesicles in many different cellu- 
lar  processes  including  endocytosis,  exocytosis,  protein 
trafficking, and even the very specialized case of synaptic 
transmission, it appears logical that caveolae are not an ex- 
ception to the rule but adhere to this general mechanism. 
However, some investigators believe that caveolae are all 
static or permanent structures that can not function in en- 
docytosis or transcytosis because they can neither arise de 
novo by invagination of the cell membrane, detach from the 
cell membrane to form free cytoplasmic vesicles, nor fuse 
with  other  cellular  components  (Frokjaer-Jensen,  1980; 
Bundgaard,  1983).  Serial  sectioning of endothelium indi- 
cates that very few vesicles can be found free in the cyto- 
plasm and unattached to other vesicles which is interpreted 
as  evidence  against  the  existence  of  vesicular  budding 
(Frokjaer-Jensen,  1980). An alternate interpretation might 
be that in the time frame of specimen processing, few free 
vesicles can be found because the budding and fusion pro- 
cess once initiated is very rapid and the thermodynamic ten- 
dency favors fusion with cell membranes. In this study, it ap- 
pears that vesicles containing A-Au can be found on the cell 
surface in various stages of invagination from noncoated pits 
to fully formed vesicles, suggesting a more dynamic role for 
caveolae. The A-Au preferentially accumulated within cav- 
eolae is internalized to endosomes. Favorable sections show 
single  vesicles  attached  to,  or  apparently  docking  with, 
spherical endosomes several times the diameter of caveolae. 
Moreover, Ghitescu et al. (1986) have noted that A-Au may 
be transported across endothelium by caveolae. Once inside 
a  vesicle,  A-Au  are  discrete  large  particles  that  cannot 
directly permeate the cell membrane and therefore, can only 
be delivered to intracellular endosomes or even across the 
cell by the movement and/or fusion of hte vesicles with the 
targeted cellular components. It seems unlikely that static 
vesicles without any ability to bud from, and/or fuse to, 
membrane could accomplish endocytosis and transcytosis. 
It is still conceivable that caveolae could remain attached to 
the cell surface and also deliver their contents to nearby en- 
dosomes by intermittent fusions without budding of the vesi- 
cles from the surface. However, Hansen et al.  (1991) used 
serial thin sectioning and rapid labeling of vesicles with Con 
A to establish that coated and noncoated vesicles both can 
endocytose by pinching off completely from the plasmalem- 
ma. We do not wish to imply that all noncoated plasmalem- 
mal vesicles must be dynamic; it is quite possible that not 
all caveolae are equivalent and a subpopulation may be less 
dynamic, which may be necessary for a different function, 
such as potocytosis (Anderson et al., 1992). Our observation 
that only a subset of the vesicles (~40 %, see Table I) interact 
with the A-Au also provides evidence that subpopulations of 
caveolae may indeed exist. 
The static view for caveola seems quite incongruous with 
the observations that discrete large protein-gold complexes 
found preferentially within caveolae are ultimately delivered 
to intracellular organelles. Furthermore, if caveolae are in- 
deed static without a role in transcytosis or endocytosis, then 
the ablation of caveolae should have little, if any, affect on 
cellular transport. To the contrary, we show here that disas- 
sembly of caveolae with sterol binding agents is associated 
with not only a very significant loss in the transport into and 
across endothelial cells but also reduced capillary perme- 
ability. Although at this time we can not rule out the possibil- 
ity of confounding multiplicity of effects elicited by filipin 
resulting in altered transport by other as yet unknown mecha- 
nisms, it seems most logical to accept the simplest apparent 
explanation  based  on  the  current  available  data.  Filipin 
reduces the caveolae density in endothelium which inhibits 
caveolae-mediated endocytosis,  transcytosis and  capillary 
permeability of select macromolecules. 
It is interesting to note that unlike coated vesicles, non- 
coated plasmalemmal vesicles, especially in the endothelium, 
can join together to form strings of vesicles in a racemose, 
treelike structure. In a logical permutation of  the classic "fer- 
ryboat" or "shuttling" hypothesis for vesicular transcytosis, 
Michel (1992) has proposed that the racemose caveolae may 
indeed be more permanent structures with only the termi- 
nally  attached  vesicles being involved in  actual  transport 
or transcytosis.  This  so-called "fission-fusion" hypothesis 
maintains that vesicles do not form de novo nor move from 
one side of the cell all the way across to the other side of the 
cell but merely far enough to fuse with the most immediate, 
neighboring caveolar tree so as to allow release of their con- 
tents back to the outside milieu on the  other side of the 
cell not directly but by diffusion through the "pores" of the 
other linked vesicles of the caveolar tree. This mechanism 
represents a refined permutation describing transcytosis and 
appears to involve "shuttling" in a more limited fashion be- 
tween the terminal ends of neighboring caveolar trees lo- 
cated on opposite sides of the cell. Lastly, vesicles may par- 
ticipate  in  transport  across  the  cell  by  forming  patent 
transendothelial channels through the fusion of interconnect- 
ing  luminal  and  abluminal  caveolae  (Wagner  and  Chen, 
1991). Although this latter mechanism may provide passage 
for some molecules, it seems an unlikely pathway for provid- 
ing  direct  specific  transport  of select  molecules  into  or 
across the cell. 
The controversy over transport via discrete vesicular car- 
riers is an old one that has existed not only in the area of 
microvascular transport and capillary permeability but also 
in many other fields such as coated vesicular endocytosis and 
protein trafficking and secretion in general. In these latter 
cases, the vesicular carrier hypothesis has held true and is 
now widely accepted. It may now be time to accept caveolae 
as  another type of transport  vesicle which  like  clathrin- 
coated vesicles can function in both intracellular and trans- 
cellular  transport.  Furthermore,  caveolae  may  resemble 
other  vesicles involved in  subcellular trafficking in  other 
ways. Our recent studies indicate that caveolae-mediated en- 
docytosis and transcytosis described in this study can also 
be inhibited by N-ethylmaleimide, suggesting as previously 
described for other vesicular processes that this transport 
pathway requires membrane fusion dependent on a NEM- 
sensitive factor(s) (Schnitzer et al.,  1995). Lastly, purifica- 
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derived directly from rat lungs shows that they have the ap- 
propriate  molecular machinery for the specific transport of 
albumin via binding to albondin (Schnitzer,  J.  E.,  P. Oh, 
B. S. Jacobson, and A. M.  Dvorak.  1994. Mol. Biol.  Cell. 
5:75A). 
In summary,  modified albumins such as A-Au bind the en- 
dothelial cell surface with high affinity, preferentially  within 
caveolae to initiate  their internalization  to endosomes and 
lysosomes for degradation. Caveolae provide a novel mecha- 
nism for scavenger endocytosis of nonnative proteins such as 
modified albumins apparently via selective interactions with 
gp30 and gpl8.  The selective disassembly of caveolae with 
cholesterol binding  agents  such  as  filipin significantly  re- 
duces caveolae-mediated  scavenger  endocytosis and degra- 
dation without functionally disrupting  the coated vesicular 
degradative  pathway. Likewise, caveolae-mediated transcy- 
tosis of albumin and insulin is significantly  inhibited whereas 
paracellular transport  through  the intercellular junctions is 
not affected by filipin treatment.  Albumins capillary perme- 
ability in the rat lung is reduced significantly.  Although this 
study does not discern between the various models of vesicu- 
lar transcytosis,  it does show that ablation of caveolae with 
filipin treatment is associated with inhibition of the transport 
of select macromolecules not only into the cell (endocytosis) 
but also across the cell (transcytosis).  Furthermore, filipin's 
selectivity in the disruption of caveolae may provide a useful 
tool for separating  not only intracellular  transport mediated 
by coated vs. noncoated vesicles but also transvascular trans- 
port in endothelium occurring via paracellular or transcellu- 
lar pathways.  Caveolae not only transport  many  molecules 
by fluid-phase uptake as originally proposed at their discov- 
ery in endothelium but now it is clear that they can also pro- 
vide an independently regulated, receptor-mediated pathway 
for specific intracellular and transcellular  processing of a va- 
riety of select ligands. 
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